While IL-9-neutralizing antibodies reduced the anticancer activity of cGAMP in both MC38 and B16-F10 tumor models (figure 1H), neutralization of IL-4 and IL-17 had no effect on cGAMP-mediated tumor growth control (figure 1I, J). The gene discussed is IL9; the disease is neoplasm.